CN104274680A - 一种治疗淋巴结结核的中药 - Google Patents
一种治疗淋巴结结核的中药 Download PDFInfo
- Publication number
- CN104274680A CN104274680A CN201410579142.8A CN201410579142A CN104274680A CN 104274680 A CN104274680 A CN 104274680A CN 201410579142 A CN201410579142 A CN 201410579142A CN 104274680 A CN104274680 A CN 104274680A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- gram
- traditional chinese
- tuberculous lymphadenitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 201000007227 lymph node tuberculosis Diseases 0.000 title abstract description 16
- 241000522620 Scorpio Species 0.000 claims abstract description 16
- 239000009490 scorpio Substances 0.000 claims abstract description 16
- 241000255791 Bombyx Species 0.000 claims description 15
- 241001161070 Calomela Species 0.000 claims description 15
- 241000282324 Felis Species 0.000 claims description 15
- 241000287828 Gallus gallus Species 0.000 claims description 15
- 241000972155 Moschus Species 0.000 claims description 15
- 241000131808 Scolopendra Species 0.000 claims description 15
- 230000000694 effects Effects 0.000 abstract description 23
- 238000011282 treatment Methods 0.000 abstract description 17
- 210000004185 liver Anatomy 0.000 abstract description 9
- 238000011084 recovery Methods 0.000 abstract description 6
- 206010010904 Convulsion Diseases 0.000 abstract description 5
- 230000036461 convulsion Effects 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 231100000614 poison Toxicity 0.000 abstract description 2
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 241000447394 Desmos Species 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 241000282326 Felis catus Species 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000001914 calming effect Effects 0.000 abstract 1
- 229940075397 calomel Drugs 0.000 abstract 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 abstract 1
- 230000004089 microcirculation Effects 0.000 abstract 1
- 210000000582 semen Anatomy 0.000 abstract 1
- 239000003440 toxic substance Substances 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 208000025865 Ulcer Diseases 0.000 description 9
- 210000001165 lymph node Anatomy 0.000 description 9
- 201000008827 tuberculosis Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000036269 ulceration Effects 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 206010016717 Fistula Diseases 0.000 description 4
- 230000003890 fistula Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 3
- 206010000269 abscess Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 238000012913 prioritisation Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000589 cicatrix Anatomy 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 238000010410 dusting Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 206010056377 Bone tuberculosis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000009360 Osteoarticular Tuberculosis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000002612 cardiopulmonary effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 208000037922 refractory disease Diseases 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/28—Mercury; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8884—Arisaema, e.g. Jack in the pulpit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Inorganic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种治疗淋巴结结核的中药,选取的原料药及其重量组份分别是:蜈蚣20-30克、全蝎10-20克、白芥子10-20克、僵蚕10-20克、猫头骨10-20克、天南星8-15克、麝香8-15克、鸡爪皮8-15克、轻粉8-15克、浙贝8-15克。诸药共伍,共奏息风止痉,攻毒散结,通络止痛和疏通肝经之功,药物能促进机体血管扩张,改善微循环,打通受阻肝经,使淋巴腺结核得以治疗。临床试验证明用此中药治疗淋巴结结核具有制作简便、疗效确切、安全可靠、治愈率高且不复发等优势,值得临床推广和应用。
Description
技术领域
本发明属中药领域,具体的说是一种可以治疗淋巴结结核的中药。
背景技术
淋巴结结核,中医称之为瘰疬,是体现于肌表的毒块组织,主要是由肝肺两方面的痰毒热毒凝聚所成。西医则指,人体内有专事于清毒杀毒从而保护血管,组织的淋巴系统,遭遇来自体内外无法清除杀灭的毒菌,凝聚和集结于肌表组织形成的毒瘤。
淋巴结核是最为常见的肺外结核之一,近几年有不断增多趋势,一旦患者患淋巴结结核,给患者带来很大的痛苦,如果延误治疗,易形成瘘管和窦道,迁延不愈,不但花费高,受痛苦大,还严重影响患者的身心健康。目前临床治疗淋巴结结核,多采用抗痨及手术切除治疗,也有的用中药及偏方治疗,但时好时犯,容易复发,不能彻底根治,导致此病成为临床难治病症之一。
发明内容
本发明克服了目前在治疗淋巴结结核方面存在的技术不足,提供了一种疗效确切、价格低廉、无副作用、治愈率高且不易复发的中药。
本发明所采用的技术方案为:一种治疗淋巴结结核的中药,其特征在于,所述中药由以下重量份的中药原材料组成:
蜈蚣20-30克、全蝎10-20克、白芥子10-20克、僵蚕10-20克、猫头骨10-20克、天南星8-15克、麝香8-15克、鸡爪皮8-15克、轻粉8-15克、浙贝8-15克。
作为这一种优化方案:
所述中药由以下重量份的中药原材料组成:
蜈蚣20克、全蝎10克、白芥子10克、僵蚕10克、猫头骨10克、天南星8克、麝香8克、鸡爪皮8克、轻粉8克、浙贝8克。
作为这一种优化方案:
所述中药由以下重量份的中药原材料组成:
蜈蚣25克、全蝎15克、白芥子15克、僵蚕15克、猫头骨15克、天南星12克、麝香12克、鸡爪皮12克、轻粉12克、浙贝12克。
作为这一种优化方案:
所述中药由以下重量份的中药原材料组成:
蜈蚣30克、全蝎20克、白芥子20克、僵蚕20克、猫头骨20克、天南星15克、麝香15克、鸡爪皮15克、轻粉15克、浙贝15克。
上述中药的服用方法为:取蜈蚣25克、全蝎15克、白芥子15克、僵蚕15克、猫头骨15克、天南星12克、麝香12克、鸡爪皮12克、轻粉12克、浙贝12克,将上述中药烘干后用打粉机或家用料理机粉碎成粉状,过细筛,分为4份,每份加入一个鲜鸡蛋搅匀,按照蒸蛋方式蒸熟食之。每天早晚各吃2个(晚上临睡前服用效果更好)。
上述中药的原料中药:
蜈蚣,味辛,性温;归肝经。具有熄风止痉,解毒散结,通络止痛之功效。
全蝎,味辛,性平;归肝经。具有熄风止痉,解毒散结,通络止痛之功效。
白芥子,味辛,性温;归肺经。具有温肺祛痰,利气散结,通络止痛之功效。
僵蚕,味咸、辛,性平;归肝、肺、胃经。具有祛风定惊,化痰散结之功效。
猫头骨,味甘、温;归肺、大肠经。具有收敛痈疽,杀虫治疳之功效。
天南星,味苦、辛,温;归肺、肝、脾经。具有燥湿化痰,祛风解痉之功效。
麝香,味辛,性温;归心、脾经。具有开窍醒神,活血通经,消肿止痛之功效。
鸡爪皮,味辛,性温;归肺经。具有止痛,杀虫之功效。主要用于治疗瘰疬。
轻粉,味辛,性寒;归大肠、小肠经。具有杀虫、消积、劫痰、逐水之功效,该药善入经络。
浙贝,味苦,性寒;归肺、心经。具有化痰止咳,清热散结之功效。
淋巴结结核,俗称“鼠疮”,中医叫“瘰疬”,主要是由结核杆菌侵犯而患病,祖国医学认为该病主要为热毒内攻,瘀血内阻所致。本发明中药中,蜈蚣、全蝎、麝香能熄风止痉,解毒散结,通络止痛;白芥子、僵蚕、浙贝、天南星配伍可温肺祛痰,清热散结,祛风解痉;鸡爪皮、轻粉、猫头骨能杀虫消积,劫痰逐水,收敛痈疽。诸药配伍精良,共奏息风止痉,攻毒散结,通络止痛和疏通肝经之功,能促进机体血管扩张,改善淋巴结核病灶周围的血液循环,消除体内热毒及瘀血,使病人临床症状及肿块得以迅速好转,达到临床治愈的目的。本中药弥补了过去单纯西药抗痨时间长、疗效差、副作用多、易反复等不足之处,值得临床推广和应用。
为进一步考察本发明药物的临床疗效,我们选择了50例门诊患者进行临床试验,所有病例均符合颈部淋巴结核的诊断标准。患处可见多个淋巴结肿大,严重时融合成团块,有触痛,质地中度硬,有个别患者伴随午后发烧,夜间盗汗等临床症状。50例患者中,男26例,女24例,年龄10~65岁,平均25.6岁;合并肺结核者15例,胸膜炎者6例,胸腔结核者3例,骨结核者2例。所有患者随机分为治疗组与对照组,每组25例,根据临床症状,淋巴结核临床具体分型为治疗组:结节型8例,浸润型7例,脓肿型8例,溃疡瘘管型2例;对照组:结节型7例,浸润型8例,脓肿型9例,溃疡瘘管型1例;两组患者在年龄、性别、病情等方面比较,差异无显著性意义(P>0.05),具有可比性。
治疗方法:
对照组给予常规抗结核方案(2HRZE/7HR),治疗组采用本发明中药,具体为取蜈蚣25克、全蝎15克、白芥子15克、僵蚕15克、猫头骨15克、天南星12克、麝香12克、鸡爪皮12克、轻粉12克、浙贝12克,将上述中药烘干后用打粉机或家用料理机粉碎成粉状,过细筛,分为4份,每份加入一个鲜鸡蛋搅匀,按照蒸蛋方式蒸熟食之。每天早晚各吃2个。
疗效标准:
痊愈:临床症状完全消失,肿大的淋巴结肿块消失,破溃的伤口愈合。
显效:临床症状大部分消失,肿大的淋巴结缩小2/3。
有效:临床症状有所好转,肿大的淋巴结缩小1/3。
无效:临床症状无变化,肿块无变化或恶化者。
疗效结果:
1.临床疗效比较:
治疗3个月后,治疗组痊愈12例,显效9例,有效3例,无效1例,治愈率为48.0%,有效率为96.0%;对照组痊愈4例,显效7例,有效8例,无效6例,治愈率16.0%,有效率76.0%。治疗组的痊愈率、有效率明显高于对照组,组间比较差异显著(P<0.05),有统计学意义。详细结果见表1。
表1:两组治疗后临床疗效结果对照表
组别 | 例数 | 痊愈n(%) | 显效n(%) | 有效n(%) | 无效n(%) | 总有效率(%) |
治疗组 | 25 | 12(48.0) | 9(36.00) | 3(12.0) | 1(4.0) | 96.0 |
对照组 | 25 | 4(16.0) | 7(28.00) | 8(32.0) | 6(24.0) | 76.0 |
2.临床分型疗效结果比较:
通过临床淋巴结核患者按照结节型、浸润型、脓肿型、溃疡瘘管型封分型判定疗效,治疗组疗效明显优于对照组,组间比较差异显著(P<0.05),有统计学意义。详细结果见表2。
表2:临床分型疗效结果比较表
3.药物不良反应:
治疗过程中,对照组出现2例患者丙氨酸氨基转移酶(ALT)及冬氨酸氨基转移酶(AST)升高,1例出现白细胞降低,经对症处理后均未影响继续治疗。两组均未发现肾功能损害。
结果表明,本发明中药在治疗淋巴结结核上安全可靠,效果确切,副作用少,基本上不受任何年龄,体质及各种现存疾病的影响,被治愈的淋巴腺结核患者避免了手术打击和抗痨药物长期应用所造成的肝、肠损伤,减少了患者的痛苦,大大提高了淋巴结结核患者的生存质量,值得临床推广和应用。
具体实施方式
实施例1:一种治疗淋巴结结核的中药,选取蜈蚣20克、全蝎10克、白芥子10克、僵蚕10克、猫头骨10克、天南星8克、麝香8克、鸡爪皮8克、轻粉8克、浙贝8克。
实施例2:一种治疗淋巴结结核的中药,选取蜈蚣25克、全蝎15克、白芥子15克、僵蚕15克、猫头骨15克、天南星12克、麝香12克、鸡爪皮12克、轻粉12克、浙贝12克。
实施例3:一种治疗淋巴结结核的中药,选取蜈蚣30克、全蝎20克、白芥子20克、僵蚕20克、猫头骨20克、天南星15克、麝香15克、鸡爪皮15克、轻粉15克、浙贝15克。
下面通过具体病例对本发明的中药疗效进一步进行验证:
病例1
宋某,男,22岁。患者一年前无明显诱因右侧颈部淋巴结突然肿大,1周后肿块达2×2.5cm大小,质软,无粘连,压痛,活动较好,伴有发热、盗汗等症状。因工作较忙,适逢朋友介绍本发明中药,遂服用治疗。用药半月后,感觉肿块明显缩小,临床体征明显改善,服药1个月后,肿大的淋巴结缩小2/3以上,继续治疗1个月,肿块全部消失,临床痊愈。随访半年未见复发。
病例2
吕某,女,43岁。患者患有颈淋巴结核3年余,期间因为颈淋巴结多次肿大,破溃、双侧皮肤由于瘢痕、结痂、变形、一年四季脖子上总是离不开包扎的敷料痛苦不堪。今年3月,患者淋巴结又开始破溃、流脓、邻近的淋巴结肿大,于是在朋友引荐下,开始服药本药物治疗,治疗1个月时,肿大的淋巴结缩小2/3以上,破溃的脓腔缩小,结痂的疤痕组织比较过去自然破溃的疤痕小且规整。继续服药1个月后,淋巴结恢复正常,破溃现象也消失,临床体征明显改善,患者痊愈。随访3个月未见复发。
病例3
华某,女,33岁。患者于2年前无明显诱因出现右颈部淋巴结肿大,医院检查确诊为颈淋巴结结核,抗痨治疗一年,稍好转后又复发,致使患者体质消瘦。因对西药治疗无信心,于是经人介绍改用本发明药物治疗,治疗前检查显示右颈淋巴结肿大约3×3.2cm大小,表面无溃破,心肺正常。治疗一个月后,肿块明显缩小,治疗2个月后症状肿块全部消失,后继续服用半个月加以巩固疗效,患者痊愈。随访一年未见复发。
Claims (4)
1.一种治疗淋巴结结核的中药,其特征在于,所述中药由以下重量份的中药原材料组成:
蜈蚣20-30克、全蝎10-20克、白芥子10-20克、僵蚕10-20克、猫头骨10-20克、天南星8-15克、麝香8-15克、鸡爪皮8-15克、轻粉8-15克、浙贝8-15克。
2.根据权利要求1所述的中药,其特征在于,所述中药包括以下重量克的中药原材料:
蜈蚣20克、全蝎10克、白芥子10克、僵蚕10克、猫头骨10克、天南星8克、麝香8克、鸡爪皮8克、轻粉8克、浙贝8克。
3.根据权利要求1所述的中药,其特征在于,所述中药包括以下重量克的中药原材料:
蜈蚣25克、全蝎15克、白芥子15克、僵蚕15克、猫头骨15克、天南星12克、麝香12克、鸡爪皮12克、轻粉12克、浙贝12克。
4.根据权利要求1所述的中药,其特征在于,所述中药包括以下重量克的中药原材料:
蜈蚣30克、全蝎20克、白芥子20克、僵蚕20克、猫头骨20克、天南星15克、麝香15克、鸡爪皮15克、轻粉15克、浙贝15克。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410579142.8A CN104274680A (zh) | 2014-10-24 | 2014-10-24 | 一种治疗淋巴结结核的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410579142.8A CN104274680A (zh) | 2014-10-24 | 2014-10-24 | 一种治疗淋巴结结核的中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104274680A true CN104274680A (zh) | 2015-01-14 |
Family
ID=52250341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410579142.8A Pending CN104274680A (zh) | 2014-10-24 | 2014-10-24 | 一种治疗淋巴结结核的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104274680A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104958340A (zh) * | 2015-06-26 | 2015-10-07 | 四川金堂海纳生物医药技术研究所 | 一种治疗淋巴结结核的新型结核散及其制备方法 |
CN104971117A (zh) * | 2015-06-25 | 2015-10-14 | 四川金堂海纳生物医药技术研究所 | 一种治疗淋巴结结核的内服药物及其制备方法 |
CN106421287A (zh) * | 2016-10-26 | 2017-02-22 | 黔西南州神力中草药应用开发研究所 | 一种治疗淋巴结核及肿瘤的药物及其制备方法 |
CN107281224A (zh) * | 2017-07-25 | 2017-10-24 | 李国欣 | 一种治疗淋巴癌的外用发酵中药液 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102258675A (zh) * | 2011-08-05 | 2011-11-30 | 刘翠传 | 四虫漆贝胶囊 |
-
2014
- 2014-10-24 CN CN201410579142.8A patent/CN104274680A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102258675A (zh) * | 2011-08-05 | 2011-11-30 | 刘翠传 | 四虫漆贝胶囊 |
Non-Patent Citations (1)
Title |
---|
何国兴: "麝香临床新用", 《甘肃中医学院学报》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104971117A (zh) * | 2015-06-25 | 2015-10-14 | 四川金堂海纳生物医药技术研究所 | 一种治疗淋巴结结核的内服药物及其制备方法 |
CN104958340A (zh) * | 2015-06-26 | 2015-10-07 | 四川金堂海纳生物医药技术研究所 | 一种治疗淋巴结结核的新型结核散及其制备方法 |
CN106421287A (zh) * | 2016-10-26 | 2017-02-22 | 黔西南州神力中草药应用开发研究所 | 一种治疗淋巴结核及肿瘤的药物及其制备方法 |
CN107281224A (zh) * | 2017-07-25 | 2017-10-24 | 李国欣 | 一种治疗淋巴癌的外用发酵中药液 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103055052B (zh) | 一种治疗烧伤、烫伤的膏剂及其制备方法 | |
CN104274680A (zh) | 一种治疗淋巴结结核的中药 | |
CN103961553A (zh) | 一种治疗麻醉药不良反应的药物及制备方法 | |
CN103893557A (zh) | 一种治疗褥疮的中药制剂 | |
CN103463516B (zh) | 一种治疗脚气的中药药膏及制备方法 | |
CN107375845A (zh) | 祛风除湿通经活络的外用组合物及其使用方法 | |
CN110075258A (zh) | 一种糖尿病足溃疡外用药 | |
CN102119975A (zh) | 一种治疗溃疡和褥疮及血管炎性感染性皮肤病的中草药药膏 | |
CN104352687A (zh) | 治疗外痔的药物及其制备方法 | |
CN104013884A (zh) | 一种治疗小儿支气管炎的中药组合物 | |
CN103191378B (zh) | 一种用于治疗骨质增生的酒及制备方法 | |
CN103877391B (zh) | 一种治疗支气管炎的中药制剂及制备方法 | |
CN105853562A (zh) | 一种用于治疗哮喘的中药制剂及制备方法 | |
CN105663157A (zh) | 一种治疗火烧烫伤的药物及其制备方法 | |
CN108553616B (zh) | 一种具有治疗胸部疼痛功效的中草药热奄包 | |
CN105194399A (zh) | 一种治疗肋骨骨折的中药药膏及制备方法 | |
CN103285339B (zh) | 一种治疗骨痛病的外用药物 | |
CN105327290B (zh) | 一种治疗糖尿病坏疽的外用中药及其制备方法 | |
CN104523879A (zh) | 治疗骨折用酒剂及制备方法 | |
CN108310273A (zh) | 一种外用药膏 | |
CN104383135A (zh) | 一种治疗丹毒的中药制剂及其使用方法 | |
CN108653588A (zh) | 一种治疗骨科疾病的外敷中药 | |
CN106822734A (zh) | 一种通痹止痛外敷药袋 | |
CN103127483B (zh) | 一种治疗脉管炎的外敷药及其制备方法 | |
CN103211911A (zh) | 一种治疗血栓闭塞性脉管炎的药物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150114 |